Möchten Sie immer auf dem neuesten Stand bleiben?

Erstellen Sie noch heute ein Leserkonto, um die Branchen und Unternehmen zu verfolgen, die Sie interessieren, und passen Sie Ihr Nachrichten-Dashboard an.

Beim Leserkonto Anmelden Leserkonto Erstellen

06. Mai 2009 13:35 ET | Quelle: NanoGuardian

White Paper Examines the Importance of On-Dose Technologies in the Fight Against Illegal Diversion of Opioid Medications

SKOKIE, IL--(Marketwire - May 6, 2009) - NanoGuardian™, a division of NanoInk® that delivers brand protection solutions to fight illegal diversion and counterfeiting, announced today...
04. Februar 2008 14:32 ET | Quelle: WHITECOAT Strategies, LLC

WHITECOAT Strategies, LLC, Opens for Business, Challenges Clients to "Put More Life in Your Science"

WASHINGTON, DC--(Marketwire - February 4, 2008) - With over 100 years of collective staff experience, WHITECOAT Strategies, LLC, opens today to serve science and technology driven clients, including...
20. Februar 2003 09:02 ET | Quelle: Nestle S.A.

Alcon Reports Strong Fourth Quarter and Full-year 2002 Results

HUNENBERG, Switzerland, Feb. 20, 2003 (PRIMEZONE) -- Alcon, Inc. (NYSE:ACL) reported global sales of USD 749.2 million for the fourth quarter of 2002, an increase of 11.7 percent over sales in the...
23. Januar 2003 01:52 ET | Quelle: Novartis

Novartis Meets Full-Year Double-Digit Sales Growth Objective with Strong Operating Performance in 2002

BASEL, Switzerland, Jan. 23, 2003 (PRIMEZONE) -- Novartis (NYSE:NVS): -- Group sales up 11% in local currencies (2% in CHF) thanks to strong volume growth in Pharmaceuticals and Generics ...
02. Mai 2002 04:09 ET | Quelle: ReadSoft

Spanish Distribution Firm Turns to ReadSoft for Invoices Capture

STOCKHOLM, Sweden, May 2, 2002 (PRIMEZONE) -- ReadSoft has closed a deal with the largest Pharmaceutical Distribution Group in Spain, Unycop, who will use ReadSoft's software INVOICES to process...
26. April 2002 05:33 ET | Quelle: Medivir

Medivir: Interim Report, 1 January - 31 March 2002 (with link)

HUDDINGE, Sweden, April 26, 2002 (PRIMEZONE) -- Medivir: - MIV-606 against shingles: US market rights outlicensed to Reliant Pharmaceuticals, raising a SEK 50 m up-front payment. Medivir...
24. April 2002 11:16 ET | Quelle: Pharmexa A/S

Pharmexa A/S: Inoxell Receives Acceptance of its Scaffold Technology Patent from the European Patent Office

HORSHOLM, Denmark, April 24, 2002 (PRIMEZONE) -- Pharmexa's 83.3% owned subsidiary Inoxell A/S today announced that the European Patent Office has issued an acceptance of Inoxell's patent on its...
27. März 2002 03:16 ET | Quelle: CeNeS Pharmaceuticals Plc

CeNeS Announces Preliminary Results for the Year- Ended December 31, 2001 (with link)

CAMBRIDGE, U.K., March 27, 2002 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) today announced its results for the year ended Dec. 31, 2001 and an update on its restructuring plan. Key events...
22. März 2002 03:03 ET | Quelle: CompanynewsGroup

Solvay Group: Final 2001 Results; Confirmation of Net Current Earnings of EUR 403 million; Net Dividend Maintained at EUR 1.70 per Share

BRUSSELS, Belgium, March 22, 2002 (PRIMEZONE) -- Results of the Solvay Group (Euronext Brussels:SOLB) (Xetra:SOL) and the parent company, Solvay S.A. As announced on February 18, 2002, the Solvay...
27. Februar 2002 13:15 ET | Quelle: BioPhausia

BioPhausia: Year end report 2001 (with link)

UPPSALA, Sweden, February 27, 2002 (PRIMEZONE) -- BioPhausia reports year-end results and significant events. -- Sales amounted to SEK 2.071.000 (SEK 975.000) -- Rights for RescueFlow(r)...

Vorherige Seite